Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis
Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis have?
Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis has 14 citations in the OpenAlex counts ScholarIQ stores.
When was Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis published?
Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis has 2024 year in the ScholarIQ index.
What is the open-access status of Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis?
Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis has hybrid oa status in the ScholarIQ index.
What is the DOI of Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis?
The DOI for Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis is on the source record.
What is the PMID of Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis?
The PMID for Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis is on the source record.
What is the OpenAlex record for Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis?
The OpenAlex for Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis is on the source record.